- Hemopneumothorax as an Unusual and Delayed Complication of Coronavirus Disease 2019 Pneumonia: A Case Report
-
Sayan M, Turk MS, Ozkan D, Kankoc A, Tombul I, Celik A
- KMID: 2523187
- J Chest Surg.
- 2021 Dec;54(6):521-523.
- doi: 10.5090/jcs.20.149
The increasing number of studies published on coronavirus disease 2019 (COVID-19) pneumonia has improved our knowledge of the disease itself and its complications. Despite a considerable number of publications on... -
- CITED
-
- Close
- SHARE
-
- Close
- Survival Effect of Complete Multimodal Therapy in Malignant Pleural Mesothelioma
-
Sayan M, Bas A, Turk MS, Ozkan D, Celik A, Kurul , Tastepe AI
- KMID: 2533513
- J Chest Surg.
- 2022 Oct;55(5):405-412.
- doi: 10.5090/jcs.22.037
Background: Malignant pleural mesothelioma (MPM) is an aggressive pleural malignancy, and despite all multimodal treatment modalities, the 5-year overall survival rate of patients with MPM is less than 20%. In... -
- CITED
-
- Close
- SHARE
-
- Close
- Prognostic Analysis of Primary Pulmonary Malignant Mesenchymal Tumors Treated Surgically
-
Sayan M, Kankoc A, Ozkan D, Celik A, Kurul IC, Tastepe AI
- KMID: 2521106
- J Chest Surg.
- 2021 Oct;54(5):356-360.
- doi: 10.5090/jcs.21.032
Background: Primary pulmonary malignant mesenchymal tumors are rare, constituting only 0.4% of all lung cancers. Since sarcomas are chemo/radio-resistant, surgical resection is the optimal treatment choice for patients with suitable... -
- CITED
-
- Close
- SHARE
-
- Close
